Abstract
This article explores the use of silver in the management of wound infection and odour from a clinical governance perspective. It relates issues of risk assessment and management, clinical effectiveness and evidence-based care, clinical audit and quality assurance to the care of patients with or at risk of a wound infection. A case study is included on the use of Actisorb Silver 220 in the management of a leg ulcer patient.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
